Small interfering ribonucleic acid for cholesterol lowering – Inclisiran
Daniel Soffer, Robert M. Stoekenbroek, Roda Plakogiannis
Topics & Concepts
MedicineTolerabilityStatinPCSK9GuidelineClinical trialIntensive care medicineEzetimibeInternal medicinePharmacologyAdverse effectCholesterolLipoproteinLDL receptorPathologyLipoproteins and Cardiovascular HealthPharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life